0001628280-24-024972.txt : 20240523
0001628280-24-024972.hdr.sgml : 20240523
20240523163423
ACCESSION NUMBER: 0001628280-24-024972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Breeden Richard C
CENTRAL INDEX KEY: 0001300622
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38848
FILM NUMBER: 24978897
MAIL ADDRESS:
STREET 1: 100 SOUTH WACKER
STREET 2: SUITE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001757898
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 35312322000
MAIL ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: STERIS Ltd
DATE OF NAME CHANGE: 20181101
4
1
wk-form4_1716496445.xml
FORM 4
X0508
4
2024-05-21
0
0001757898
STERIS plc
STE
0001300622
Breeden Richard C
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN
L2
2
IRELAND
1
0
0
0
0
Ordinary Shares
2024-05-21
4
M
0
4584
51.53
A
32554
D
Ordinary Shares
27242
I
See Footnotes Below
Director Stock Option (right to buy)
51.53
2024-05-21
4
M
0
4584
0
D
2024-08-06
Ordinary Shares
4584
0
D
Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund").
Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP.
This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2024-05-23